Search - tctmd.com

Displaying 201 - 220 of 297

Sort: Relevancy | Date

News Daily News

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

L.A. McKeown

March 22, 2022

News Daily News

Guideline-Directed Therapies Underused in Frail HF Patients

L.A. McKeown

March 11, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

FDA Approves Empagliflozin for Treatment of HFpEF

Michael O'Riordan

February 24, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News THT 2022

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Shelley Wood

February 02, 2022

Presentation THT 2022

Clinical Data and Patient Experience with Barostim

Presenter: Nirav Raval

February 02, 2022

Presentation THT 2022

Mechanism of Action of Baroreflex Activation Therapy

Presenter: Marat Fudim

February 02, 2022

Presentation THT 2022

The Need for Device Therapy in HFrEF

Presenter: William Abraham

February 02, 2022

Presentation THT 2022

The Cunundrum of Afib and HFrEF / HFpEF

Presenter: Nassir Marrouche

February 02, 2022

Presentation THT 2022

Vagal Nerve Stimulation and ANTHEM-HFrEF

Presenter: Marvin A. Konstam

February 02, 2022

Presentation THT 2022

Design and Rationale of the CORCINCH-HF pivotal study

Presenter: Ulrich Jorde

February 01, 2022

Presentation THT 2022

12-Month Outcomes for the AccuCinch System in HFrEF

Presenter: Nadira Hamid

February 01, 2022

Presentation THT 2022

From Access to Anchors: The AccuCinch Ventricular Restoration System

Presenter: Mohamed Latib

February 01, 2022

Presentation THT 2022

Reverse Remodeling in Heart Failure

Presenter: Daniel Burkhoff

February 01, 2022

Presentation THT 2022

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Presenter: Sanjiv Shah

February 01, 2022

Presentation THT 2022

Evidence for Revascularization in HFrEF Patients

Presenter: Kathleen Kearney

February 01, 2022

Presentation THT 2022

CAD and HFrEF: Mind the Gap

Presenter: Adam DeVore

February 01, 2022

Presentation THT 2022

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

Presenter: Marat Fudim

February 01, 2022

Presentation THT 2022

SGLT2 Inhibitors in HFrEF and HFpEF

Presenter: Stefan Anker

February 01, 2022

Advertisement

Empagliflozin Plus an MRA Is Safe in HFpEF, May Help With Hyperkalemia

Guideline-Directed Therapies Underused in Frail HF Patients

March 2022 News Roundup

FDA Approves Empagliflozin for Treatment of HFpEF

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Early Positive Signals From RELIEVE-HF Shift Discussion to Atrial Shunt Size

Clinical Data and Patient Experience with Barostim

Mechanism of Action of Baroreflex Activation Therapy

The Need for Device Therapy in HFrEF

The Cunundrum of Afib and HFrEF / HFpEF

Vagal Nerve Stimulation and ANTHEM-HFrEF

Design and Rationale of the CORCINCH-HF pivotal study

12-Month Outcomes for the AccuCinch System in HFrEF

From Access to Anchors: The AccuCinch Ventricular Restoration System

Reverse Remodeling in Heart Failure

Long-term follow-up on FIH experience using the Satera Ablation System in HFpEF and HFrEF

Evidence for Revascularization in HFrEF Patients

CAD and HFrEF: Mind the Gap

Overview of the physiology of the splanchnic bed in HFpEF and HFrEF

SGLT2 Inhibitors in HFrEF and HFpEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content